Author

G. Shevchenko

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

A. B. Addinsall· 1 shared A. Backeus· 1 shared A. M. Davis· 1 shared J. Bergquist· 1 shared K. V. Morris· 1 shared L. Larsson· 1 shared N. Cacciani· 1 shared Y. Hedstrom· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

A. B. Addinsall

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Electrical Stimulated GLUT4 Signaling Attenuates Critical Illness-Associated Muscle Wasting

A. B. Addinsall, N. Cacciani, A. Backeus, Y. Hedstrom, G. Shevchenko, J. Bergquist, L. Larsson

This study shows chronic supramaximal electrical stimulation reduces critical illness-associated muscle wasting in rats by maintaining GLUT4 translocation and reducing protein degradation through AMPK-TBC1D4 and AMPK-FoxO3 pathways.

bioRxiv · Nov 11, 2021 · PreprintPhysiology

Hypoxia-directed tumor targeting of CRISPR/Cas9 and HSV-TK suicide gene therapy using lipid nanoparticles

A. M. Davis, K. V. Morris, G. Shevchenko

This study develops a hypoxia-targeted gene therapy system using CRISPR/Cas9 and HSV-TK delivered via lipid nanoparticles, showing effective tumor cell killing under hypoxia without affecting normoxic cells.

bioRxiv · Sep 30, 2021Cancer Biology